Immunosuppressant Management in Renal Transplant Patients with COVID-19

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2021 Oct 25

PMID 34692845

Citations 5

Authors

Elham Ahmadian

Sepideh Zununi Vahed

Shakar Mammadova

Sima Abediazar

Affiliations

Soon will be listed here.

Abstract

The coronavirus disease 2019 (COVID-19) pandemic poses a special risk for both immunosuppressed patients, especially transplant recipients. Although the knowledge about this infection is growing, many uncertainties remain, particularly regarding the kidney. Kidney transplant recipients (KDRs) should be considered immunocompromised hosts since a potential risk for infection, comorbidity, and immunosuppression exposure exists. Additionally, the management of immunosuppressive agents in KDRs remains challenging. Potential drug interactions with immunosuppressive treatment escalated the risk of unwanted side effects. In this review, we aimed to attain an augmented awareness and improved management immunosuppressant for COVID-19 KDRs.

Citing Articles

Risk factors for SARS-CoV-2 infection and severe COVID-19 in unvaccinated solid organ transplant recipients.

Vrij C, Bogaerts K, Vermeersch P, Lagrou K, Molenberghs G, Rega F Sci Rep. 2024; 14(1):26465.

PMID: 39488631 PMC: 11531510. DOI: 10.1038/s41598-024-78119-6.

Immune characteristics of kidney transplant recipients with acute respiratory distress syndrome induced by COVID-19 at single-cell resolution.

Lu J, Chen Y, Zhou K, Ling Y, Qin Q, Lu W Respir Res. 2024; 25(1):34.

PMID: 38238762 PMC: 10795319. DOI: 10.1186/s12931-024-02682-9.

Risk factors for SARS-CoV-2 pneumonia among renal transplant recipients in Beijing Omicron wave.

Li G, Wu J, Huang Y, Wang Q, Xing T, Ou T Microbiol Spectr. 2024; 12(2):e0300523.

PMID: 38230924 PMC: 10846129. DOI: 10.1128/spectrum.03005-23.

Tacrolimus and Cyclosporin Pharmacotherapy, Detection Methods, Cytochrome P450 Enzymes after Heart Transplantation.

Tolou-Ghamari Z Cardiovasc Hematol Agents Med Chem. 2023; 22(2):106-113.

PMID: 37496131 DOI: 10.2174/1871525721666230726150021.

A systematic review and meta-analysis of the seroconversion rates and adverse effects of COVID-19 mRNA vaccine and COVID-19 viral vector vaccine in kidney transplant recipient patients.

Chen S, Wei W, Huang F, Wang J, Li X, Geng Z Hum Vaccin Immunother. 2023; 19(1):2196893.

PMID: 37057765 PMC: 10120468. DOI: 10.1080/21645515.2023.2196893.

References

Kumar D, Tellier R, Draker R, Levy G, Humar A . Severe Acute Respiratory Syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening. Am J Transplant. 2003; 3(8):977-81. PMC: 7175989. DOI: 10.1034/j.1600-6143.2003.00197.x. View

Miarons M, Larrosa-Garcia M, Garcia-Garcia S, Los-Arcos I, Moreso F, Berastegui C . COVID-19 in Solid Organ Transplantation: A Matched Retrospective Cohort Study and Evaluation of Immunosuppression Management. Transplantation. 2020; 105(1):138-150. DOI: 10.1097/TP.0000000000003460. View

Lu X, Chen T, Wang Y, Wang J, Yan F . Adjuvant corticosteroid therapy for critically ill patients with COVID-19. Crit Care. 2020; 24(1):241. PMC: 7235543. DOI: 10.1186/s13054-020-02964-w. View

Pascual J, Berger S, Witzke O, Tedesco H, Mulgaonkar S, Qazi Y . Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation. J Am Soc Nephrol. 2018; 29(7):1979-1991. PMC: 6050928. DOI: 10.1681/ASN.2018010009. View

Cheung C, Poon L, Ng I, Luk W, Sia S, Wu M . Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J Virol. 2005; 79(12):7819-26. PMC: 1143636. DOI: 10.1128/JVI.79.12.7819-7826.2005. View

Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis T, Politou M . Hematological findings and complications of COVID-19. Am J Hematol. 2020; 95(7):834-847. PMC: 7262337. DOI: 10.1002/ajh.25829. View

Chiu M . Suggested management of immunocompromized kidney patients suffering from SARS. Pediatr Nephrol. 2003; 18(12):1204-5. PMC: 7087636. DOI: 10.1007/s00467-003-1325-8. View

Hu B, Huang S, Yin L . The cytokine storm and COVID-19. J Med Virol. 2020; 93(1):250-256. PMC: 7361342. DOI: 10.1002/jmv.26232. View

Sanders J, Monogue M, Jodlowski T, Cutrell J . Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020; 323(18):1824-1836. DOI: 10.1001/jama.2020.6019. View

10.

Nikolich-Zugich J, Knox K, Rios C, Natt B, Bhattacharya D, Fain M . SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes. Geroscience. 2020; 42(2):505-514. PMC: 7145538. DOI: 10.1007/s11357-020-00186-0. View

11.

Shi Y, Wang Y, Shao C, Huang J, Gan J, Huang X . COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020; 27(5):1451-1454. PMC: 7091918. DOI: 10.1038/s41418-020-0530-3. View

12.

Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H . Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020; 130(5):2620-2629. PMC: 7190990. DOI: 10.1172/JCI137244. View

13.

Staatz C, Tett S . Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients. Clin Pharmacokinet. 2007; 46(1):13-58. DOI: 10.2165/00003088-200746010-00002. View

14.

Horby P, Lim W, Emberson J, Mafham M, Bell J, Linsell L . Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2020; 384(8):693-704. PMC: 7383595. DOI: 10.1056/NEJMoa2021436. View

15.

Abassi Z, Knaney Y, Karram T, Heyman S . The Lung Macrophage in SARS-CoV-2 Infection: A Friend or a Foe?. Front Immunol. 2020; 11:1312. PMC: 7291598. DOI: 10.3389/fimmu.2020.01312. View

16.

Bartiromo M, Borchi B, Botta A, Bagala A, Lugli G, Tilli M . Threatening drug-drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID-19). Transpl Infect Dis. 2020; 22(4):e13286. PMC: 7262190. DOI: 10.1111/tid.13286. View

17.

Kochi A, Tagliari A, Forleo G, Fassini G, Tondo C . Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol. 2020; 31(5):1003-1008. PMC: 7262150. DOI: 10.1111/jce.14479. View

18.

Giacobbe D, Battaglini D, Ball L, Brunetti I, Bruzzone B, Codda G . Bloodstream infections in critically ill patients with COVID-19. Eur J Clin Invest. 2020; 50(10):e13319. PMC: 7323143. DOI: 10.1111/eci.13319. View

19.

Johnson K, Belfer J, Peterson G, Boelkins M, Dumkow L . Managing COVID-19 in Renal Transplant Recipients: A Review of Recent Literature and Case Supporting Corticosteroid-sparing Immunosuppression. Pharmacotherapy. 2020; 40(6):517-524. PMC: 7267490. DOI: 10.1002/phar.2410. View

20.

Engelmann C, Sterneck M, Weiss K, Templin S, Zopf S, Denk G . Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant Centers. J Clin Med. 2020; 9(8). PMC: 7465768. DOI: 10.3390/jcm9082352. View